Citius Pharmaceuticals Inc vs MINISO Group Holding Ltd — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while MINISO Group Holding Ltd trades at $11.97 (market cap $3.62B). The key difference: MINISO Group Holding Ltd is far larger — about 180.9× Citius Pharmaceuticals Inc's market cap, and MINISO Group Holding Ltd pays a 5.53% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | MNSO | |
|---|---|---|
Market Cap | $20.01M | $3.62B |
Sector | Health | Technology |
52-Week High | $1.82 | $26.63 |
52-Week Low | $0.48 | $11.30 |
Enterprise Value | $16.23M | $4.29B |
Dividend Yield | — | 5.53% |
Trailing returns across standard periods
Latest headlines on both assets
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.
Read more on MNSO →